APM
EPIX

Avidity Partners Management’s ESSA Pharma EPIX Stock Holding History

Avidity Partners Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,855,400
Closed -$4.68M – 87
2022
Q4 		$4.68M Sell
1,855,400
-604,600
-25% -$1.74M 0.11% 70
2022
Q3 		$4.48M Hold
2,460,000
– – 0.1% 82
2022
Q2 		$7.75M Hold
2,460,000
– – 0.18% 53
2022
Q1 		$15.2M Hold
2,460,000
– – 0.34% 57
2021
Q4 		$34.9M Buy
2,460,000
+10,000
+0.4% +$111K 0.74% 43
2021
Q3 		$19.6M Sell
2,450,000
-300,000
-11% -$4.77M 0.5% 54
2021
Q2 		$78.6M Sell
2,750,000
-90,000
-3% -$2.62M 2.12% 13
2021
Q1 		$82.5M Buy
2,840,000
+282,000
+11% +$6.56M 2.3% 10
2020
Q4 		$30.5M Buy
2,558,000
+470,200
+23% +$3.31M 1.03% 37
2020
Q3 		$14.4M Buy
+2,087,800
New +$14.2M 0.78% 41

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return